Tobacco.org

CHEST: No Sex Difference Found in COPD Treatment  

Action Points

* Explain to interested patients that this analysis fails to support suggestions that women may respond differently to COPD treatment.

* Note that this study was published as an abstract and presented at a conference. These data and conclusions should be considered preliminary until published in a peer-reviewed journal.

SAN DIEGO -- Men and women with chronic obstructive pulmonary disorder (COPD) derive comparable benefits from treatment with tiotropium (Spiriva), researchers found.

A secondary analysis of a large clinical trial found improvements of similar magnitude in lung function, exacerbations, and health-related quality of life in both genders, according to Donald Tashkin, MD, of the University of California Los Angeles.

Jump to full article »